Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Neuroscience Research|August 10, 2015
Ultrastructural analysis of olfactory ensheathing cells derived from olfactory bulb and nerve of neonatal and juvenile ratsRosa M Gómez, Kemel Ghotme, Lucía Botero, et al.Expert Opinion on Therapeutic Targets|September 24, 2024
The endocannabinoid system as a therapeutic target in neuropathic pain: a reviewJose-Manuel Quintero, Luis-Eduardo Diaz, Ismael Galve-Roperh, et al.Journal of Environmental Management|March 2, 2019
Emerging pollutants in the urban water cycle in Latin America: A review of the current literatureCarlos Peña-Guzmán, Stefanie Ulloa-Sánchez, Karen Mora, et al.Expert Opinion on Emerging Drugs|April 3, 2025
Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-beingMaria-Alejandra Umbacia, Marta Ximena Leon, Jose-Manuel Quintero, et al.F1000Research|March 24, 2025
Vancomycin Population Pharmacokinetic Models in Non- Critically Ill Adults Patients: a scoping reviewDiego Nivia, Juan-David Vivas, Wilson Briceño, et al.Antibiotics (Basel, Switzerland)|July 24, 2019
<i>Pseudomonas aeruginosa</i> Coharboring <i>Bla</i><sub>KPC-2</sub> and <i>Bla</i><sub>VIM-2</sub> Carbapenemase GenesTatiana Pacheco, Rosa Helena Bustos-Cruz, Deisy Abril, et al.F1000Research|December 21, 2023
The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adultsHans Liebisch-Rey, Andrea-Marcela Suarez-Chacon, Yuli-V Fuentes, et al.Pharmacotherapy|September 23, 2025
Lithium Augmentation in Treatment-Resistant Depression: A Qualitative Review of the LiteratureAngela Acero-González, Yahira Guzman, Nadia Juliana Proaños, et al.Current Pharmaceutical Design|March 22, 2017
Diabetes-Related Neurological Implications and PharmacogenomicsCamilo Andres Rojas-Carranza, Rosa Helena Bustos-Cruz, Carmen Juliana Pino-Pinzon, et al.Pharmaceutics|October 23, 2021
Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical OutcomesJose Sanabria, Vivian Garzón, Tatiana Pacheco, et al.Pageof 5